Page last updated: 2024-11-04

linsidomine and Kashin-Beck Disease

linsidomine has been researched along with Kashin-Beck Disease in 2 studies

linsidomine: RN given refers to parent cpd; structure

Kashin-Beck Disease: Disabling osteochondrodysplasia with OSTEOSCLEROSIS, cone-shaped METAPHYSIS, and shortening of the DIAPHYSIS. It is endemic in parts of Siberia and northern China. Mineral deficiencies (e.g., selenium, iodine), fungal cereal contamination, and water contamination may be contributing factors in its etiology.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, H1
Fang, Q1
Wang, M2
Wang, W1
Zhang, M2
Zhang, D2
He, Y2
Zhang, Y2
Wang, H1
Otero, M2
Ma, T1
Chen, J2
Jiang, Z1

Other Studies

2 other studies available for linsidomine and Kashin-Beck Disease

ArticleYear
FGF8 and FGFR3 are up-regulated in hypertrophic chondrocytes: Association with chondrocyte death in deep zone of Kashin-Beck disease.
    Biochemical and biophysical research communications, 2018, 06-02, Volume: 500, Issue:2

    Topics: Animals; Biomarkers; Cartilage, Articular; Cell Death; Cell Differentiation; Cell Line; Child; Child

2018
3-morpholinosydnonimine (SIN-1)-induced oxidative stress leads to necrosis in hypertrophic chondrocytes in vitro.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 106

    Topics: Animals; Apoptosis; Cartilage; Case-Control Studies; Cell Line; Cell Survival; Chondrocytes; Dose-Re

2018